• Use of infliximab within a Patient support program- positive perception of iv Infusions from Patients’ perspective

    May 1, 2015, 00:00

  • Comparative Risk of Transfusion And Incremental Total Hospitalization Cost Of Primary Unilateral, Bilateral, And Revision Total Knee Arthroplasty Procedures

    May 1, 2015, 00:00

  • Characteristics of Products with Price changes after a policy change in Egypt

    May 1, 2015, 00:00

  • Impact of tolerability profiles on HTA decision making in Oncology

    May 1, 2015, 00:00

  • Possibilities Of Childhood Vaccinations

    May 1, 2015, 00:00

  • Whole-Disease Model Approach- Methodologies And Challenges In Communicating The Economic Burden Of Rare Diseases

    May 1, 2015, 00:00

  • Systematic Literature Review Of Cost Of Adverse Events In Cancer Treatments In The Us

    May 1, 2015, 00:00

  • Factors Predicting Receipt of Prostate Specific Antigen (PSA) Testing- Evidence from the national ambulatory Medical Care Survey (Namcs) data

    May 1, 2015, 00:00

  • Knowledge And Awareness Of Oral Cancer In Guntur Area,South India

    May 1, 2015, 00:00

  • Comparison of guidelines and management for Gastric Cancer Screening between Korea and Japan

    May 1, 2015, 00:00

  • Healthcare Coverage, Expenditures and Population Habits in Argentina

    May 1, 2015, 00:00

  • Systematic review with Qualitative Assessment of Antidepressant Monotherapies in Patients with Major depressive Disorder with an inadequate response to a prior SSRI or SNRI

    May 1, 2015, 00:00

  • The changing costs of caring for Hemophilia Patients in the U.S.- insurers’ and patients’ perspectives

    May 1, 2015, 00:00

  • Human Papillomavirus (HPV) Vaccination during well-Child visits in privately insured Males 9-21 years of age in the United States in 2012

    May 1, 2015, 00:00

  • Comparison of Patients With Rheumatoid Arthritis (RA) On Disease Remission In The European Union (EU) And United States (US)

    May 1, 2015, 00:00

  • All-cause 30-day readmissions among medicaid beneficiaries with selected Chronic conditions- a multi-level analysis

    May 1, 2015, 00:00

  • Tree-Based Claims Algorithm For Measuring Pre-Treatment Quality Of Care In Medicare Disabled Hepatitis C Patients

    May 1, 2015, 00:00

  • Return on Investment of Smoking Cessation Benefit Comparison In Guangdong, China

    May 1, 2015, 00:00

  • Sensitivity, specificity and level of Agreement between different criteria used to Diagnose the Metabolic Syndrome

    May 1, 2015, 00:00

  • Initiation and evaluation of Clinical Pharmacy Services to Surgical Ward in a South Indian tertiary care Teaching Hospital

    May 1, 2015, 00:00

  • Us Burden of Illness Associated With Adjuvant Therapy for Stage I-III Melanoma

    May 1, 2015, 00:00

  • Hospital-Reported Frequency Excess Cost of Foreign objects Left In The Body During Total Joint Arthroplasty

    May 1, 2015, 00:00

  • A retrospective analysis of health care resource utilization and the economic burden among u.s. Long-term care facility patients diagnosed with stroke

    May 1, 2015, 00:00

  • A Systematic Quantitative Approach To Incorporating The Patient Perspective Into Health Technology Assessment Decision Making

    May 1, 2015, 00:00

  • Life At A Premium- Considering An End-Of-Life Premium In Value-Based Reimbursement

    May 1, 2015, 00:00

  • Kidney involvement in Tuberous Sclerosis Complex- the impact on Health Care resource use and costs in the Netherlands

    May 1, 2015, 00:00

  • Time-dependence of first appropriate Therapy in primary prevention implantable cardioverter defibrillator patients- is device replacement necessary in patients without prior ICD interventions?

    May 1, 2015, 00:00

  • Defining uncontrolled diabetes from the patient Perspective- A four-country study in People with type-2 Diabetes On Basal Insulin

    May 1, 2015, 00:00

  • Proton Pump inhibitor prescribing trend in the us Ambulatory setting

    May 1, 2015, 00:00

  • Anti-Diabetic Drugs and the risk of Dementia Among Medicare Beneficiaries with diabetes

    May 1, 2015, 00:00

  • Cachexia debility in Hospitalized Children with complex Chronic conditions

    May 1, 2015, 00:00

  • Bayesian Hierarchical modeling of randomized and non-randomized studies comparing ciclosporin with immediate- and prolonged-release tacrolimus in Liver Transplant Recipients

    May 1, 2015, 00:00

  • Acute, Short-Term And Long-Term Costs Of Cardiovascular Events Among Hyperlipidemia Patients

    May 1, 2015, 00:00

  • Development and Content Validity Testing of The Patient-Reported Outcomes of Fatigue In Cancer (Proof-C) Symptom Severity Assessment (Ssa)

    May 1, 2015, 00:00

  • Modelling The Clinical And Economic Outcomes Of Variations In Intensity Of Valsartan-Centric Regimens For Hypertension

    May 1, 2015, 00:00

  • Can serologic markers of Fibrosis predict future shocks in ICD recipients with dilated Cardiomyopathy?

    May 1, 2015, 00:00

  • Assessment Of Level Of Medication Adherence In Different Non-Communicable Chronic Diseases Patient In Quetta, Pakistan- Dose Disease Condition Produces Any Change

    May 1, 2015, 00:00

  • Characteristics of Patients with Systemic Lupus Erythematosus (SLE) currently experiencing flares in clinical practice settings in Europe (EU)

    May 1, 2015, 00:00

  • Impact Of Enzalutamide or Abiraterone Acetate + Prednisone (Abp) on Quality Of Life (Qol) In The Treatment of Metastatic Castration-Resistant Prostate Cancer (mcrpc) That Has Progressed on Or After Doxetaxel- A Comparative Effectiveness Stu ...

    May 1, 2015, 00:00

  • Comparison of disease status and outcomes of Patients with Ankylosing Spondylitis (AS) receiving adalimumab or Etanercept Monotherapy in the United States (US)

    May 1, 2015, 00:00

  • Cost-effectiveness of treating Hepatitis C Virus (HCV) Genotype 1 (GT1) patients with abbvie 3D (Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir) +/- ribavirin compared to harvoni (Sofosbuvir/Ledipasvir) in the United States

    May 1, 2015, 00:00

  • Prevalence And Predictors Of Health Risk Behaviors In Undergraduate Health Sciences Students Of Khyber Medical University

    May 1, 2015, 00:00

  • The impact of Genomic testing on Chemotherapy use and medical spending in a commercially-insured population of Breast Cancer Patients

    May 1, 2015, 00:00

  • Eliciting Patient Treatment Preferences- Development Of A Methodological Framework For Attribute Identification And Validation For Discrete Choice Experiments

    May 1, 2015, 00:00

  • The Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) as an add-on to Metformin or Metformin Plus Sulphonylurea In The Treatment of Type 2 Diabetes Mellitus In Spain

    May 1, 2015, 00:00

  • Utilizing Electronic Medical Record Networks For Identifying Patients For Clinical Trial Recruitment

    May 1, 2015, 00:00

  • Trend analysis of G-BA decisions – what factors influence the Likelihood of recommendations?

    May 1, 2015, 00:00

  • Evaluation of the Quality of Life of Diabetic Patients in Minas Gerais State, Brazil

    May 1, 2015, 00:00

  • Modelling The Cost Determinants For Older Persons’ Transitions In Care (Optic)

    May 1, 2015, 00:00

  • Treatment of acute Appendicitis in Germany- results of the analysis of a Health Insurance claims database

    May 1, 2015, 00:00

  • Trends in antihypertensive medication use in us office-based practices- are elderly patients treated diffrerently?

    May 1, 2015, 00:00

  • Developing Hospital Based Hta For Egyptian Cancer Patients

    May 1, 2015, 00:00

  • Relationship of Serum Uric Acid Levels With Hypertension And Hyperlipidemia In Patients With Gout

    May 1, 2015, 00:00

  • Prevalence of Medication use not captured by prescription claims databases – an analysis using 2012 Medical Expenditure Panel Survey Data

    May 1, 2015, 00:00

  • Cost Minimization Analysis Of Immunosuppressive Treatment On Kidney Transplant Patients

    May 1, 2015, 00:00

  • Bayesian network Meta-Analysis (Nma) to Assess the relative Efficacy of Canagliflozin Monotherapy over 26 weeks In Patients with Type 2 Diabetes mellitus (T2dm)

    May 1, 2015, 00:00

  • Healthcare Resource utilization and Medical Care Cost Associated With New Bio-Surgical Hemostasis In China

    May 1, 2015, 00:00

  • Budget Impact of adding peginterferon beta-1a to the formulary for the treatment of relapsing forms of multiple Sclerosis

    May 1, 2015, 00:00

  • Administration Cost Of Pediatric Vaccination- A Focused Literature Review

    May 1, 2015, 00:00

  • Predicting Phase Iii Survival outcomes Using Phase Ii Trial Data In Nsclc and Rcc

    May 1, 2015, 00:00

  • Effect of Patient’s cost sharing on Expenditures- an Instrumental Variables Approach

    May 1, 2015, 00:00

  • Quality of evidence supporting inclusion of Pharmacogenomic biomarkers in product labels of fda approved Oncology Therapies

    May 1, 2015, 00:00

  • Description of Patients satisfaction or dissatisfaction with referral and counter referral process

    May 1, 2015, 00:00

  • Classification Tree Analysis Of The Likelihood Of Clopidogrel Treatment In A Cohort Of Patients With Symptomatic Peripheral Artery Disease

    May 1, 2015, 00:00

  • Out-of-pocket Healthcare Expenditures among patients with Chronic obstructive Pulmonary disease

    May 1, 2015, 00:00

  • Identification and Characterization of Long Term Survival Population In Non-Small-Cell Lung Cancer Patients Treated With Immunotherapies

    May 1, 2015, 00:00

  • Hospital Utilization In Patients With Ebstein’s Anomaly

    May 1, 2015, 00:00

  • Impact of Young-onset Parkinson’s Disease on Quality of Life €“ a Literature Review

    May 1, 2015, 00:00

  • Effects of Overweight and Obesity on Health service use and expenditures among U.S. adults with Chronic renal disease

    May 1, 2015, 00:00

  • DEVELOPMENT, VALIDATION, AND ANALYSIS OF A LINEAR REGRESSION MODEL PREDICTING CHILD’S BIRTHWEIGHT FROM MOTHER’S RACE, EDUCATION LEVEL, SMOKING STATUS, AND GESTATION AGE

    May 1, 2015, 00:00

  • Direct medical costs associated with Clinical and Health characteristics in visually impaired individuals in Singapore

    May 1, 2015, 00:00

  • Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) In Turkey

    May 1, 2015, 00:00

  • CRITICAL PROBLEMS OF CODING DATA IN HEALTH CARE- OBESITY, SMOKING, AND ALCOHOL USE BY METHOD OF MEASUREMENT

    May 1, 2015, 00:00

  • An Innovative Cloud-Based Platform for Implementing Performance-Based Risk-Sharing Arrangements (Pbrsas) in Oncology Settings

    May 1, 2015, 00:00

  • Characteristics of Combination Pharmacotherapy in Patients with Diabetic Painful Neuropathy (DPN)

    May 1, 2015, 00:00

  • Use of Anti-osteoporosis Medications and Fracture Risk Among Elderly Patients With End-Stage Renal Disease- A Retrospective Cohort Study

    May 1, 2015, 00:00

  • Patient- and Physician-Reported Motivations for Medication Non-Adherence or Switching In Rheumatoid Arthritis

    May 1, 2015, 00:00

  • Analysis of Adverse Drug Reactions During Pharmacotherapeutic Follow-Up of Hiv+ Patients

    May 1, 2015, 00:00

  • Cost-effectiveness of Secukinumab compared to current treatments for the treatment of moderate to severe plaque Psoriasis in Canada

    May 1, 2015, 00:00

  • The Electronic Age- Integrating Epro/Ecoa To Reduce Patient, Site, And Study Team Burden

    May 1, 2015, 00:00

  • Economic impact of using Harmonic Scalpel Technology in Surgery

    May 1, 2015, 00:00

  • Evaluating The Outcomes of A Diabetes Treatment Management Program Targeting Appropriate Anti-Hypertensive Treatment For Adults With Diabetes for Dual And Non-Dual Eligible Medicare Advantage Beneficiaries

    May 1, 2015, 00:00

  • Treatment outcomes of Smear Positive Pulmonary TB Cases Registered In TB Patients In Quetta

    May 1, 2015, 00:00

  • Overview and importance of nub process for Market Access of in-patient Drugs and devices in Germany

    May 1, 2015, 00:00

  • Building quality in hta process and decision making- can key performance measures of good practices in hta be identified?

    May 1, 2015, 00:00

  • Optimising market access of Cancer Drugs in Canada- a study of Economic reviews by the Pan-Canadian Oncology Drug review (PCODR) expert committee

    May 1, 2015, 00:00

  • Geographic Differences In Availability Of Antihypertensive Medications- A Comparison Of Australia, Canada, Saudi Arabia, Uk, And The Us

    May 1, 2015, 00:00

  • Timing of eu5 US Orphan Drug approvals and PRMA between 2009 and 2013

    May 1, 2015, 00:00

  • Cross-state comparison of medicaid Anti-Obesity medication coverage- 1999-2013

    May 1, 2015, 00:00

  • Impact of New changes due to Affordable care act on US Market Access

    May 1, 2015, 00:00

  • Improved Heor writing skills of keen interest to Bio/Pharma Heor Directors and Managers

    May 1, 2015, 00:00

  • Comparison of the impact of Human versus analogue insulins on Glycosylated Hemoglobin in a Population with Diabetes Mellitus Colombia

    May 1, 2015, 00:00

  • A Cost-effectiveness Analysis of A biomarker Test Compared to Standard of Care Surveillance in Patients With Barrett’s Esophagus

    May 1, 2015, 00:00

  • Systematic Review of Epidemiology and Burden of Pancreatic Cancer

    May 1, 2015, 00:00

  • Use of Clozapine and Antipsychotic Polypharmacy among patients with Schizophrenia- characterizing the prescribers

    May 1, 2015, 00:00

  • Loss of Productivity Costs Attributable to Being overweight or Obese In Working Asthma Patients In The Us

    May 1, 2015, 00:00

  • Agents Acting On Renin-Angiotensin System Usage In Croatia During The Fourteen-Year Period- Impact Of Generics

    May 1, 2015, 00:00

  • Lack Of Adherence To Immunosuppressive Treatment In Kidney Transplant Patients- Computer Assisted Qualitative Data Analysis (Caqdas) Of An Expert Panel

    May 1, 2015, 00:00

  • Small Benefits Of Third Trimester Check-Up Among Pregnant Women Positively Screened For Thyroid Disorders

    May 1, 2015, 00:00

  • Current Situation Of The Public-Private Partnerships For Drugs In Brazil

    May 1, 2015, 00:00

  • Analysis of Health Technology assessment requirements in 7 Asia Oceania Countries/regions- comparison of evidentiary requirements for standard and Orphan Drugs

    May 1, 2015, 00:00

  • Cost-effectiveness of AQP4 antibody detection with cell-based assay compared with elisa for devic disease Diagnosis in Colombia

    May 1, 2015, 00:00

  • Patient’s preferences for dry powder inhaler attributes in Asthma and Chronic Obstructive Pulmonary Disease- a discrete choice experiment

    May 1, 2015, 00:00

  • Estimating the cost of Pneumonia cases admitted at the internal medicine wards of a tertiary Government Hospital in the Philippines

    May 1, 2015, 00:00

  • Patients’ Groups And Advocacy In Oncology- Awareness, Support And Unmet Needs

    May 1, 2015, 00:00

  • Cross section analysis of Marginal NHS expenditure by England Health area

    May 1, 2015, 00:00

  • FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval Pathway

    May 1, 2015, 00:00

  • What factors make Economic Evaluation more valuable as a service?

    May 1, 2015, 00:00

  • Comparative outcomes of Testosterone therapy versus no Treatment in hypogonadic men

    May 1, 2015, 00:00

  • The value of non-randomised evidence for informing Clinical effectiveness- an assessment of HTA requirements and Published Guidance regarding the appropriateness of non-randomised data

    May 1, 2015, 00:00

  • Diabetes Mellitus Treatment- Cost-Effectiveness of Schemes Therapeutic Glargine and Nph - Brazil, 2014

    May 1, 2015, 00:00

  • Is visual impairement associated with increased Hospitalization? a retrospective Cohort study of community-dwelling medicare beneficiares

    May 1, 2015, 00:00

  • Physician’s Adherence To Treatment Guidelines In Deep Vein Thrombosis At An Indian Tertiary Healthcare Facility

    May 1, 2015, 00:00

  • Cost-Minimization analysis of Infliximab versus Adalimumab in the treatment of Crohn’s disease and Ulcerative Colitis

    May 1, 2015, 00:00

  • Do depression rates differ by conflict era among War Veterans?

    May 1, 2015, 00:00

  • Cost implication of using Lorcaserin in Weight Management prior to Bariatric Surgery

    May 1, 2015, 00:00

  • WITHDRAWN

    May 1, 2015, 00:00

  • Peripheral arterial disease management program- screening-risk factor management program and financial return on investment

    May 1, 2015, 00:00

  • Sex Differences In over-the-counter sleep aid use in older adults

    May 1, 2015, 00:00

  • The Processes For A Common Quality Assurance Approach To Multi-Centre Clinical Trials – The Mars Excite Experience

    May 1, 2015, 00:00

  • Pneumococcal vaccination Coverage In adults with high-risk Conditions- Missed Opportunities Continue

    May 1, 2015, 00:00

  • Availability and Use of Epinephrine Auto-Injectors for The Treatment of Anaphylaxis- Results From The Epipen4schoolsâ® Survey

    May 1, 2015, 00:00

  • Predictors of Allopurinol adherence in patients with Gout

    May 1, 2015, 00:00

  • Lack of Adherence to Immunosuppressive Treatment In Kidney Transplant Patients- Estimation of Associated Direct Medical Costs

    May 1, 2015, 00:00

  • Preferences for New Treatments Diminish In The Face of Ambiguity

    May 1, 2015, 00:00

  • Prevalence of Mental Health Disorders and access to care among children Enrolled in the mississippi medicaid

    May 1, 2015, 00:00

  • Pharmacotherapy Optimization plan for patients with type-2 Diabetes mellitus (T2DM) and Hypertension in a Chilean Healthcare setting- impact and outcomes

    May 1, 2015, 00:00

  • Evaluating Content Validity Of Performance Outcomes (Perfos)- Establishing The Patient-Relevance Of Three Perfos In Elective Total Hip Replacement (Ethr)

    May 1, 2015, 00:00

  • Systematic Review and Network Meta-Analysis of Tedizolid for the treatment of acute Bacterial Skin and Skin Structure Infection (Absssi) Due to Methicillin-Resistant Staphylococcus Aureus (Mrsa)

    May 1, 2015, 00:00

  • Federal exchanges provide Lower Premiums but Less Generous Pharmacy benefits than Employer-Sponsored Plans

    May 1, 2015, 00:00

  • Diffusion of Ultrasound among Physicians treating patients with Rheumatoid Arthritis- 2002-2013

    May 1, 2015, 00:00

  • Decreasing Ebm order Set review and approval cycle time

    May 1, 2015, 00:00

  • Lessons learned from the Pilot introduction of Peginesatide, a Third generation Erythropoiesis Stimulating Agent

    May 1, 2015, 00:00

  • Comparative Efficacy of Interventions for Overactive Bladder Syndrome- A Systematic Review And Network Meta-Analysis

    May 1, 2015, 00:00

  • Emergency disease Spectrum in China- based on Hospital database from Beijing

    May 1, 2015, 00:00

  • HIV Antiretroviral drug utilization and Expenditures In Medicaid 1991-2014

    May 1, 2015, 00:00

  • Important Statistical Considerations For Developing Equations For Disease Simulators

    May 1, 2015, 00:00

  • Assessing the economic burden of u.s. Medicare patients diagnosed with non-hodgkin’s lymphoma

    May 1, 2015, 00:00

  • Does treatment for newly-diagnosed depression reduce healthcare expenditures among medicaid beneficiaries with type 2 diabetes mellitus?

    May 1, 2015, 00:00

  • Cost-effectiveness of Ikervis® in severe dry Eye disease in the UK

    May 1, 2015, 00:00

  • Drug Use Among Seniors On Public Drug Programs In Canada, 2012

    May 1, 2015, 00:00

  • Evaluation of Audit scoring Consistency in a comprehensive feedlot Management System and correlation with feedyard performance based on average daily Gain and Dry feed conversion in 11 US feedlots

    May 1, 2015, 00:00

  • Cost Comparison of First Line Metastatic Renal Cell Carcinoma Treatments Using A Retrospective Claims Dataset

    May 1, 2015, 00:00

  • Cost per additional responder associated with Biologic use in Psoriasis

    May 1, 2015, 00:00

  • Rate of adverse event-related treatment changes and Healthcare costs associated with topical Rosacea treatment

    May 1, 2015, 00:00

  • A Cost-effectiveness analysis of Antipsychotics for treatment of Schizophrenia in Uganda

    May 1, 2015, 00:00

  • Cost effectiveness of Antiglaucoma medications

    May 1, 2015, 00:00

  • Unmet needs and treatment patterns in Lupus- results from an online Community

    May 1, 2015, 00:00

  • Biologic Adherence among Psoriasis Patients in the us Medicare Population

    May 1, 2015, 00:00

  • Health-related quality of life (HRQOL) in patients on Ombitasvir/ Paritaprevir /Ritonavir and dasabuvir at the end of 12-week treatment in treatment-naÏve adults with Genotype 1B (GT1B) Chronic Hepatitis C

    May 1, 2015, 00:00

  • Initial impact of Telepharmacy on specialty Medication adherence

    May 1, 2015, 00:00

  • Invariance of Quality of Life Questionnaire Eortc Qlqc30 In Different Cancer Indications

    May 1, 2015, 00:00

  • Economic value of preventing central venous catheter sepsis infections with early cannulaton arteriovenous grafts (ECAVGS) compared to Non-Ecavgs

    May 1, 2015, 00:00

  • Choosing between the promis global and eq-5d for comparative effectiveness research- are they really different?

    May 1, 2015, 00:00

  • An Evaluation Of Competing Models For Predicting Cv Event Rates From Ldl-C Levels In Secondary Prevention

    May 1, 2015, 00:00

  • Potential savings in Healthcare spending on “low-value” interventions- case study of Arthroscopic Knee Surgery

    May 1, 2015, 00:00

  • Suggestion Of New Methods To Calculate Confidence Interval For Incremental Cost-Effectiveness Ratio Which Solve The Issues With Conventional Method

    May 1, 2015, 00:00

  • Will U.S. payers Champion Biosimilars?

    May 1, 2015, 00:00

  • Hta Decisions And Comparator Changes Over Time In Rheumatoid Arthritis

    May 1, 2015, 00:00

  • Application Of Difference-In-Difference Methodology In Comparative Effectiveness Research With Unbalanced Groups

    May 1, 2015, 00:00

  • Differences in Breast Cancer screening rates in medicare advantage non-dual eligible members, dual eligibles enrolled in special need plans and other Healthcare Plans

    May 1, 2015, 00:00

  • Direct costs comparison of medical care before and after Heart failure Hospitalization in a Medicare Population

    May 1, 2015, 00:00

  • Prospective Study On Prescription Pattern In Tertiary Care Hospital In South India

    May 1, 2015, 00:00

  • Efficacy and Safety of Insulin Analogues Compared to Human Insulin Preparations for the treatment of Patients With Diabetes Type 1 (Dm1)- Systematic Review and Meta-Analysis

    May 1, 2015, 00:00

  • A System dynamics model for the cost-effectiveness evaluation of Bacterial whole-genome sequencing for detecting and monitoring outbreaks of MRSA

    May 1, 2015, 00:00

  • Direct Medical Costs Of Her2 Positive Breast Cancer Management In Iran- A Claims Database And Data Mining Analysis

    May 1, 2015, 00:00

  • Guidance For The Conduct And Reporting Of Modeling And Simulation In The Context Of Health Technology Assessment

    May 1, 2015, 00:00

  • Patterns of Disease Remission Among Patients With Rheumatoid Arthritis Treated With Biologic Therapies In Japan

    May 1, 2015, 00:00

  • Economic Analysis of Biologic Alternatives In The Management of Rheumatoid Arthritis, Psoriasis and ankylosing Spondylitis From Public and Private Perspectives in Brazil

    May 1, 2015, 00:00

  • Linezolid Prescription Pattern- Identifying the use to Rationalize The Practice

    May 1, 2015, 00:00

  • Psychometric Validation Of Performance Outcomes (Perfos) For Use With Hip Fracture (Hf) Populations

    May 1, 2015, 00:00

  • A Review of Patient-Reported Outcomes (pros) in Patients with Cutaneous Lupus Erythematosus (CLE)

    May 1, 2015, 00:00

  • Medication use survey of inpatients with basic Medical Insurance from 2010 to 2012

    May 1, 2015, 00:00

  • Pharmacotherapeutic and Economic indicators of the use of Immunobiologicals Drugs- analysis of a Rheumatic Patient Cohort

    May 1, 2015, 00:00

  • Real-World adherence in Medicare Patients with type 2 Diabetes Mellitus (T2dm) for exenatide qw and Liraglutide qd

    May 1, 2015, 00:00

  • Japan Pricing Methodology Analogue Assessment

    May 1, 2015, 00:00

  • Directly Eliciting Personal Utility Functions- A New Way To Value Health-Related Quality Of Life

    May 1, 2015, 00:00

  • Exploring Heterogeneity In Attribute Processing Strategies- Use Of Hybrid Random Utility Maximization-Random Regret Minimization (Rum-Rrm) Models In A Discrete Choice Experiment (Dce)

    May 1, 2015, 00:00

  • Validity And Limitations Of The Longitudinal Patient Database France For Use In Pharmacoepidemiological And Pharmacoeconomics Studies

    May 1, 2015, 00:00

  • Impact of post-surgical complications on Hospital costs and Margins

    May 1, 2015, 00:00

  • Is there utility in clinical utility modeling for Diagnostic Technologies?

    May 1, 2015, 00:00

  • Identifying Key factors for Targeting Patients most suitable for Community Health Worker program

    May 1, 2015, 00:00

  • Status Of Maternal Depression In Relation To Health-Related Quality Of Life For Pregnant Women In China- Results From A Hospital-Based Survey

    May 1, 2015, 00:00

  • Patient Preference for Real-Time Feedback In Epro Assessments for Copd Clinical Trials

    May 1, 2015, 00:00

  • Comparing The Adoption Of Epro In Clinical Research To Emr In Clinical Practice – Why Clinical Practice Is Ahead Of Research With Technology Use

    May 1, 2015, 00:00

  • Quality of Life In Adult Patients with cystic Fibrosis €“ a Systematic Review

    May 1, 2015, 00:00

  • Costs Description of Rheumatoid Arthritis Treatment In Chile For Patients Who Have Failed To Conventional Synthetic Dmards

    May 1, 2015, 00:00

  • Assessment of the Costs and outcomes of Antiretroviral Therapy In Adult Outpatients at a Tertiary Hospital In Harare, Zimbabwe

    May 1, 2015, 00:00

  • A DESCRIPTIVE ANALYSIS OF TIME TO FIRST TREATMENT WITH DISEASE-MODIFYING DRUGS (DMDS) IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE SCLEROSIS (MS)

    May 1, 2015, 00:00

  • Cost-Utility Analysis of Apixaban In Patients With Atrial Fibrillation (Af) At The Peruvian Social Security (Essalud)

    May 1, 2015, 00:00

  • Specificity and Sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica- a Meta-Analysis

    May 1, 2015, 00:00

  • Developing Sf-6d-V2- Examining The Dimensionality Of The Sf-36 Using Large Multinational Datasets

    May 1, 2015, 00:00

  • Healthcare Resource Utilization associated with dalfampridine Extended Release In Multiple Sclerosis- A Retrospective Claims Database Analysis

    May 1, 2015, 00:00

  • Cost-Effectiveness analysis and Budget Impact of an extended Versus Immediate release formulation of Metformin In Type-2 Diabetes mellitus Treatment, from the Perspective of The brazilian Public Health System

    May 1, 2015, 00:00

  • Health Impact of Trivalent, Trivalent High Dose and Quadrivalent Influenza Vaccines In older adults In ontario, Canada

    May 1, 2015, 00:00

  • Cost Effectiveness of Tofacitinib as Second Line Treatment vs Using Biological Therapies In The Treatment of Moderate Rheumatoid arthritis after Failure of dmards In Panama In 2014

    May 1, 2015, 00:00

  • The Impact of Negative Trial Results on The Use of Blood Transfusions

    May 1, 2015, 00:00

  • Assessment of Osteoporsis Knowledge And Perception Among Female University Students In Quetta, Pakistan

    May 1, 2015, 00:00

  • Patient Preferences For First-Line Maintenance Treatments For Ovarian Cancer

    May 1, 2015, 00:00

  • Association of Hepatitis C Virus infection with risk of Chronic Kidney Disease- systematic review and meta-analysis

    May 1, 2015, 00:00

  • Quality of Life of Patients With Parkinson’s Disease And Other Neurodegenerative Disorders

    May 1, 2015, 00:00

  • Efficacy And Safety of Canagliflozin among Patients with type 2 diabetes Mellitus- a Systematic review and meta-analysis

    May 1, 2015, 00:00

  • Rasch analysis of a new Patient reported outcome measure for Psoriasis Treatment (PROMPT)

    May 1, 2015, 00:00

  • Comparing total and disease specific Healthcare costs for Glaucoma Patients before and after their index Diagnosis- a retrospective claims database analysis

    May 1, 2015, 00:00

  • The Incremental Cost Of Reoperations For Bleeding Events In Cardiac And Vascular Reconstructive Surgery

    May 1, 2015, 00:00

  • Comparison of real-world hypoglycemia rates among Patients Initiating Treatment with Saxagliptin or Glipizide

    May 1, 2015, 00:00

  • Clinical Trials Registries For Systematic Reviews – An Alternative Source For Unpublished Data

    May 1, 2015, 00:00

  • Inpatient Versus Outpatient Treatment Related to Exacerbation Episodes In Chronic Obstructive Pulmonary Disease (Copd) From A Public Mexican Institutional Perspective)

    May 1, 2015, 00:00

  • Alemtuzumab Budget Impact Analysis in Relapsing-Remitting Multiple Sclerosis in the US

    May 1, 2015, 00:00

  • Determining patterns of Opioid misuse and misprescribing in South Carolina

    May 1, 2015, 00:00

  • Cost-effectiveness of Aflibercept in the treatment of wet age-related Macular Degeneration in Turkey

    May 1, 2015, 00:00

  • Does oral cholecalciferol supplementation improves pain intensity and disability in patients with chronic low back pain?

    May 1, 2015, 00:00

  • A Comparison of G-BA’s additional benefit score to NICE ICERs

    May 1, 2015, 00:00

  • Assessment Of Drug Utilization Pattern And Clinical Outcome In Pregnancy Induced Hypertension In Teritary Care Hospital

    May 1, 2015, 00:00

  • United States decision maker perceptions of data from observational studies and other Health Economics and outcomes research

    May 1, 2015, 00:00

  • THE BUDGET IMPACT OF DUORESP® SPIROMAX® (BUDESONIDE + FORMOTEROL FUMARATE DIHYDRATE) COMPARED WITH COMMONLY PRESCRIBED DRY POWDER INHALERS FOR THE MANAGEMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UNITED KINGDOM- IMPACT ...

    May 1, 2015, 00:00

  • Real-World Practice Patterns For The Treatment Of Complicated Skin And Skin Structure Infections In Europe- A Retrospective Database Analysis

    May 1, 2015, 00:00

  • Analysis Of Treatment Cost For Uterine Fibroids In Ukraine

    May 1, 2015, 00:00

  • Trends in the prevalence of Dementia among the Medicare Beneficiaries- 2001-2010

    May 1, 2015, 00:00

  • Patients’ And Physicians’ Time Trade-Off Preferences For Adverse Outcomes Associated With Metastatic Colorectal Cancer Treatments

    May 1, 2015, 00:00

  • Effects of Autologous fat grafting systems on inpatient operating room time and costs- a Hospital budget impact analysis

    May 1, 2015, 00:00

  • Estimating Clinical and Economic Outcomes Following a Diabetes-Related vascular Complication

    May 1, 2015, 00:00

  • Comparison Of Different Metabolic Syndrome Criteria And Individual Risk Factors In The Risk Prediction Of Cardiovascular And Chronic Diseases

    May 1, 2015, 00:00

  • Change in Healthcare Utilization and costs in Patients with Major Depressive Disorder (MDD) initiating adjunctive Therapy with Second-Generation Antipsychotics (SGAS)

    May 1, 2015, 00:00

  • Use of Health belief model to understand Knowledge, Attitudes And Behaviors of People Towards The Ebola outbreak

    May 1, 2015, 00:00

  • Effectiveness And Cost-Effectiveness Of Catheter-Directed Thrombolysis In Massive Pulmonary Embolism

    May 1, 2015, 00:00

  • Knowledge, attitude and perceptions of Hospital Pharmacists towards pharmacists led interventions to reduce adverse Drug reactions, Drug interactions, and Pharmaceutical care issues towards better Pharmaceutical care planning- a qualitative ...

    May 1, 2015, 00:00

  • Budget Impact Analysis of Botulinum Toxin A Therapy For Upper Limb Spasticity In Hong Kong

    May 1, 2015, 00:00

  • Depression treatment patterns among individuals with Chronic Obstructive Pulmonary disease

    May 1, 2015, 00:00

  • Estimating the Health Benefits of Meeting the Healthy People 2020 objectives for reducing Invasive Colorectal Cancer Incidence In the united states

    May 1, 2015, 00:00

  • Common reasons for and associated costs of Pediatric inpatient admissions in the United States

    May 1, 2015, 00:00

  • Estimating The Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban In Non-Valvular Atrial Fibrillation

    May 1, 2015, 00:00

  • Universal screening identifies higher Thyroid Dysfunction in pregnancy. evidence based meta-analysis

    May 1, 2015, 00:00

  • Treatment for substance use and implications for Mortality in elderly prostate Cancer Patients

    May 1, 2015, 00:00

  • Expansion of current HPV Vaccination guidelines to include Men who have Sex with Men who are 27 years or older – a value of information analysis

    May 1, 2015, 00:00

  • Measurement of Health State Utilities For Relapsed or Refractory Peripheral T-Cell Lymphoma By using time trade-off And Visual Analog Scale Method

    May 1, 2015, 00:00

  • Evaluating The Economic Implications of Nonadherence And Antibody-Mediated Rejection In Renal Transplant Recipients- The Role of Once-Daily, Prolonged-Release Tacrolimus In The Uk Setting

    May 1, 2015, 00:00

  • Health economic model to measure the impact of a stemi initiative in Romania

    May 1, 2015, 00:00

  • Evaluation Of A Pharmaceutical Risk-Sharing Agreement When Patients Are Screened For The Probability Of Success

    May 1, 2015, 00:00

  • Comparing The Eq-5d-3l And Sf-6d Utility Scores Of Acute Coronary Syndrome Patients From An Asian Population

    May 1, 2015, 00:00

  • Study of Patient Related outcomes of Type 2 Diabetes and Comparative analysis of pioglitazone sales pre and post ban in Mumbai,India

    May 1, 2015, 00:00

  • Impact of Dipeptidyl Peptidase-4 Inhibitors on The Risk of Cardiovacular-Related Hsopitalizations

    May 1, 2015, 00:00

  • Assessing the Impact of Pegylated-Interferon/Ribavirin Therapy Duration Versus Viral Response on Health-Related Quality of Life (Qol) Outcomes In Chronic Hepatitis C Virus (Hcv) Patients, Using Multivariate Mixed-Effects Modeling

    May 1, 2015, 00:00

  • Past trends and current challenges in the hepatitis c reimbursement landscape- is history repeating itself?

    May 1, 2015, 00:00

  • The Cost-Effectiveness of Meniscal Repair Versus Partial Meniscectomy- A Model-Based Projection of Clinical Outcomes And Costs In The United States Healthcare System

    May 1, 2015, 00:00

  • Patient reported outcomes reveal discordance between Patient and Physician assessment of disease burden in patients with Rheumatoid Arthritis

    May 1, 2015, 00:00

  • Trends associated with Implementing and Lifting a step Therapy Policy for pregabalin in the humana Medicare Population- an Interrupted time series analysis

    May 1, 2015, 00:00

  • Correlation between Pain Catastrophizing scale and disease characteristics in Chronic Low Back Pain Patients

    May 1, 2015, 00:00

  • Pharmacoepidemiology of Cellular/Tissue derived products for the treatment of Diabetic foot ulcers in outpatient care settings

    May 1, 2015, 00:00

  • Cost of a Pharmacist-Led Pneumonia education and immunization program for older Philadelphians

    May 1, 2015, 00:00

  • Implications Of The Inter-Relatedness Of The Proportional And Absolute Qaly Shortfall Measurements For Disease Burden

    May 1, 2015, 00:00

  • Estimating the cost-effectiveness of left Atrial Appendage closure compared to warfarin for stroke prevention in Atrial Fibrillation

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Smoking Cessation Interventions In Japan Using The Discrete Event Simulation Model

    May 1, 2015, 00:00

  • Humanistic and Economic outcomes among patients receiving Percutaneous Intervention

    May 1, 2015, 00:00

  • Humanistic Burden of Chronic Spontaneous Urticaria In Comparison to Psoriasis- US And European Perspective

    May 1, 2015, 00:00

  • A Review of intraoperative interventions to prevent staple line leaks and Bleeds during Bariatric Surgical Procedures

    May 1, 2015, 00:00

  • Direct Medical Cost Comparison Between Patients Receiving Cangrelor And Clopidogrel During Percutaneous Coronary Intervention- Champion Phoenix Economic Sub-Study Results

    May 1, 2015, 00:00

  • Pralatrexate Treatment In Patients With Relapsed Or Refractory Peripheral T-Cell Lymphoma- A Systematic Review And Meta-Analysis

    May 1, 2015, 00:00

  • A Retrospective Cohort Study to investigate actual treatment for Glaucoma using a Japanese Healthcare Database

    May 1, 2015, 00:00

  • Americans’ Cancer Information (CI) Seeking Experiences and Self-Efficacy (SE) in seeking Cancer Information (CI)- a characteristic snapshot using 2012-13 Health Information National Trends Survey (HINTS)

    May 1, 2015, 00:00

  • Factors Affecting Immunization Timeliness In Malaysia

    May 1, 2015, 00:00

  • Antimicrobial Utilisation in Slovak Hospitals

    May 1, 2015, 00:00

  • Metformin and Intensive lifestyle intervention for pre-diabetes - systemati Review of Efficacy

    May 1, 2015, 00:00

  • Economic and patient burden of Lipohypertrophy in Chinese patients with Diabetes

    May 1, 2015, 00:00

  • Burden of Disease and Economic Impact of Malaria In Colombia, 2012

    May 1, 2015, 00:00

  • Oral disease modifying therapy for multiple sclerosis; is this the new normal?

    May 1, 2015, 00:00

  • Economic Aspects of Influenza Vaccination In Ukraine

    May 1, 2015, 00:00

  • Temporal Trend and Prevalence of Ckd Stages (Kdigo 2012) in Us Adults with Type 2 Diabetes Mellitus and demographic Subgroups- Nhanes 2007-2012

    May 1, 2015, 00:00

  • Risk of Glucocorticoid-related adverse events in Patients with Systemic Lupus Erythematous- findings from a 12-year Longitudinal follow-up study in Taiwan

    May 1, 2015, 00:00

  • Getting The Full Picture- The Importance Of Exrapolating Beyond The Data

    May 1, 2015, 00:00

  • Study of Psychological stress and ACNE vulgaris among Pharmacy Students

    May 1, 2015, 00:00

  • Who is spending where- analysis of Healthcare spending by Medicaid and Private Payers in Massachusetts

    May 1, 2015, 00:00

  • Trajectories of Buprenorphine treatment and Associated Emergency Department and inpatient use in a large Medicaid Program

    May 1, 2015, 00:00

  • Demonstrating the cost effectiveness of Movantik for the treatment of opioid induced constipation in Patients with inadequate response to Laxatives; a UK perspective

    May 1, 2015, 00:00

  • The Impact of Access to Cancer Care on Adjuvant Endocrine Therapy Use Among Breast Cancer Survivors in Appalachia

    May 1, 2015, 00:00

  • Use of multiple concurrent Antipsychotics in Children enrolled in the Mississippi Medicaid Program

    May 1, 2015, 00:00

  • Estimation of direct healthcare costs of gynecologic cancer in the u.s.- an analysis of 2007-2011 medical expenditure panel survey (meps) data

    May 1, 2015, 00:00

  • When The Literal Meaning Just Won’t Do - Cultural Adaptation Issues Resolved During The Linguistic Validation Of A Behavioural Scale

    May 1, 2015, 00:00

  • Matching-Adjusted Indirec Treatment Comparison And Survival Extrapolation In Radioiodine-Refractory Differentiated Thyroid Cancer (Rai-Refractory Dtc)

    May 1, 2015, 00:00

  • A Retrospective Analysis of the Economic Burden Among Patients Diagnosed with Chronic Migraine using the Veterans Health Administration Medical data

    May 1, 2015, 00:00

  • Reimbursement Approval of Oncology Drugs In Canada Supported By a Data Package Lacking Phase III Trial Data

    May 1, 2015, 00:00

  • A Review of Clinical outcome Assessments used in FDA approved Drug labels for Mental Health conditions

    May 1, 2015, 00:00

  • Healthcare resource utilization associated with rescue Medication use in adult Patients With Seizure Clusters- a retrospective chart Review

    May 1, 2015, 00:00

  • Derivation of A Preference-Based Measure for Metastatic Breast Cancer Using The Eortc Qlq-30 And Qlq-Br 23

    May 1, 2015, 00:00

  • Public Perspectives On Cost-Related Non-Adherence Among Patients

    May 1, 2015, 00:00

  • Impact of non-medical switching on Healthcare costs- a claims database analysis

    May 1, 2015, 00:00

  • Comparing tyrosine kinase inhibitor treatment strategies for newly diagnosed chronic myeloid leukemia in chronic phase when imatinib loses patent exclusivity in the u.s.- a cost-effectiveness analysis

    May 1, 2015, 00:00

  • Patterns of Care In The Workup And Management of Non-Metastatic And Metastatic Colorectal Cancer

    May 1, 2015, 00:00

  • Economics Of Diabetes Mellitus- Theory And Evidence For Brazilian Data In 2008

    May 1, 2015, 00:00

  • Impact of Surgical Site Infections following common Ambulatory Procedures on Healthcare Costs

    May 1, 2015, 00:00

  • Real-World Statin Utilization Among Patients At High Risk for Cardiovascular Events- Us Analyses

    May 1, 2015, 00:00

  • Estimating Quality of Life of Patients with Lipodystrophy

    May 1, 2015, 00:00

  • Economic implications of increasing usage of Calcium-Free balanced crystalloid solutions (BAL) versus 0.9% saline for intravenous (IV) fluid Therapy in patients with Systemic Inflammatory Response Syndrome (SIRS) in us Hospitals

    May 1, 2015, 00:00

  • Impact of Medication Therapy Management (MTM) pilot program on Healthcare Utilization and costs among Texas medicaid patients with Hypertension

    May 1, 2015, 00:00

  • Canadian retrospective claims data analysis of Biologics switching and retention patterns in Psoriasis Patients

    May 1, 2015, 00:00

  • Long-term impact of a Pharmacist-Led Diabetes medication management program on Glycemic control

    May 1, 2015, 00:00

  • Real-World Outcomes of Acute Ischemic Stroke Patients In The Medicare Population

    May 1, 2015, 00:00

  • The Burden Of Uncertainty In Emergency Room- The Case Of Chest Pain

    May 1, 2015, 00:00

  • Implementation Of Nice Clinical Guidelines (Cg) – What Can Be Learned From A Uk Case Study And How To Ensure That Health Services Do Not Fall Short Of Their Obligations

    May 1, 2015, 00:00

  • Perceptions of community Pharmacists about their current professional role, inter professional learning and continue professional development in Pakistan

    May 1, 2015, 00:00

  • Patient-Reported Outcomes (Pros) In Bladder Cancer

    May 1, 2015, 00:00

  • Prevalence And Predictor Of Antidepressants Use During Pregnancy In The Us- An Nhanes Study

    May 1, 2015, 00:00

  • Examining the impact of a Hybrid Clinical Pharmacy practice model on medication adherence in patients with Metabolic Syndrome

    May 1, 2015, 00:00

  • Assessing the impact of varying threshold criteria for Opioid Overutilization

    May 1, 2015, 00:00

  • Antihypertensive Drug Utilization In Elderly Outpatients In Serbia

    May 1, 2015, 00:00

  • The Impact of Different Types of Health Insurance on The Hospitalization Services Utilization of Patients With Hemorrhagic Stroke In China

    May 1, 2015, 00:00

  • Utilization and Payment of ERCP-related operations and medical supplies in China BMI inpatients

    May 1, 2015, 00:00

  • Epidemiology of advanced Therapies for the treatment of Diabetic foot ulcers in outpatient care settings

    May 1, 2015, 00:00

  • Comparative efficacy and Safety of Antidiabetic Drug Regimens Added to Stable and Inadequate metformin and thiazolidinedione therapy In type 2 diabetes

    May 1, 2015, 00:00

  • Impact of Medicaid managed care expansion on access to providers in Mississippi

    May 1, 2015, 00:00

  • Short- and Long-Term Survival Associated With Laparoscopic Versus open Colectomy In Early-Stage Colon Cancer- Findings From a Retrospective Cohort Study

    May 1, 2015, 00:00

  • Cost-Effectiveness Of Riociguat For Treatment Of Patients With Inoperable Or Post-Operative Recurrent/Persistent Chronic Thromboembolic Pulmonary Hypertension (Cteph) In Turkey

    May 1, 2015, 00:00

  • Validation And Valuation Of The Preference-Based Healthindex Using Eq-5d-5l In The Hong Kong Population

    May 1, 2015, 00:00

  • Communicating risk of Medication side effects- how rare is ‘rare’ and how likely is ‘likely’?

    May 1, 2015, 00:00

  • Development and Validation of a clostridium difficile quality of life Questionnaire

    May 1, 2015, 00:00

  • Uterine fibroid treatment patterns in the three years following Diagnosis

    May 1, 2015, 00:00

  • Comparison of quantiferon TB-GOLD (QFT-GIT) test versus tuberculin skin test (TST) for latent tuberculosis infection (LTBI) screening among national guard general population in Saudi Arabia

    May 1, 2015, 00:00

  • The Impact of Endoscopic Linear Stapling Device Stability in Thoracic Surgery- a Delphi Panel Approach

    May 1, 2015, 00:00

  • Ibrutinib for the treatment of Mantle Cell Lymphoma (MCL)- evaluating the correlation between patient-reported outcomes and durability of response in a Phase 2 study

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Female Human Papillomavirus Vaccination In Mainland China

    May 1, 2015, 00:00

  • Are we really measuring access? systematic review of access measures to Medicines in Brazil

    May 1, 2015, 00:00

  • Comparison Of Machine Learning, Statistical And Hybrid Methods To Identify Predictors Of Positive Treatment Outcomes In Comorbid Conditions Using Emr Data

    May 1, 2015, 00:00

  • Companion devices- transformative Mobile Health Technology towards improved patient care delivery

    May 1, 2015, 00:00

  • Once-Daily Single-tablet Regimen Reduce Loss to Follow-up In People Living With Hiv

    May 1, 2015, 00:00

  • Effect of Florida’s prescription monitoring Program and pill-mill Laws on Opioid prescribing and Utilization

    May 1, 2015, 00:00

  • Clopidogrel Versus Aspirin In Patients With Atherothrombosis- A Caprie-Based Economic Analysis In A Health Resource Limited Setting

    May 1, 2015, 00:00

  • Cost analysis of patients with acute Coronary event in a Commercial Insurance Company in Colombia —Saludcoop— in 2013

    May 1, 2015, 00:00

  • Relationship between the development of Electronic Health records and Hospital accreditation decisions in Fran results from the E-SI (preps-sips) study

    May 1, 2015, 00:00

  • Cost-Effectiveness of Refractory Asthma Treatment Strategies- A Decision Tree Analysis

    May 1, 2015, 00:00

  • Office-based uterine polypectomy using a minimally invasive Hysteroscopic tissue removal device saves Healthcare resources

    May 1, 2015, 00:00

  • Mapping Utility Scores from European organization for Treatment of Cancer Core-30 Questionnaire Scores (Eortc Qlq-C30) In Relapsed Multiple Myeloma

    May 1, 2015, 00:00

  • Remote monitoring strategies for patients with stable Heart failure- a systematic review and Network meta-analysis

    May 1, 2015, 00:00

  • The Use Of Low Molecular Weight Heparin And Pneumatic Compression Devises For Deep Vein Thrombosis Prophylaxis In Major Trauma Patients- A Comparative Effectiveness Analysis

    May 1, 2015, 00:00

  • Is there an impact of the Orphan designation in Oncology on market access in Europe?

    May 1, 2015, 00:00

  • Patient reported outcomes- are they relevant to u.s. Payers?

    May 1, 2015, 00:00

  • Patients sent to the emergency department by advanced healthcare providers are more likely to need admission

    May 1, 2015, 00:00

  • Utilization of Negative Controls to Examine association between Rare Genetic Disorders and Type 2 Diabetes in four Large Observational Databases

    May 1, 2015, 00:00

  • Comparative effectiveness of Fibrin sealants in Cardiac Surgery

    May 1, 2015, 00:00

  • Management of tuberous Sclerosis complex in England- insights into Real-World Clinical practice

    May 1, 2015, 00:00

  • The Californian Technology assessment forum – the arrival of cost-utility appraisals of Drugs in the USA?

    May 1, 2015, 00:00

  • The budget impact of treating Patients with Non-Diabetic Peripheral Neuropathic Pain (PNP) with capsaicin 8% patch for either Pregabalin-Naive or Pregabalin-Treated Patients in Scotland

    May 1, 2015, 00:00

  • Assessing the availability of Drugs marketed in the US and Switzerland

    May 1, 2015, 00:00

  • The Cost-Effectiveness of Canagliflozin Versus Sitagliptin as Third-Line Therapy in Type 2 Diabetes Mellitus (T2dm) in a Canadian setting

    May 1, 2015, 00:00

  • Cost Effectiveness of Apixaban For Stroke Prevention In Non Valvular Atrial Fibrillation In The Ecuatorian Public Healthcare Sector

    May 1, 2015, 00:00

  • The impact of alternative Antipsychotic Medications on the risk of adverse events in patients treated for Schizophrenia

    May 1, 2015, 00:00

  • HEALTH RELATED QUALITY OF LIFE AND HEALTH CARE RESOURCE USE BURDEN IN MIGRAINE WITH AND WITHOUT NAUSEA

    May 1, 2015, 00:00

  • The Burden of Aml Within the

    May 1, 2015, 00:00

  • Safety of Tofacitinib Compared to Biological Dmards In Rheumatoid Arthritis Patients With An Inadequate Response to Methotrexate- overview of Systematic Reviews

    May 1, 2015, 00:00

  • The rise of the value analysis committee at Us Hospitals, better or worse for medical device companies?

    May 1, 2015, 00:00

  • A Cost Comparison of Split-Dose Reduced-Volume oral Sulfate Solution (OSS) And Polyethylene Glycol With Electrolytes Solution (Peg-Els)

    May 1, 2015, 00:00

  • Estimating the cost-Effectiveness of 12 weeks of treatment with Daclatasvir+Sofosbuvir In Patients Chronically Infected With hcv Genotype 3

    May 1, 2015, 00:00

  • Evaluation Of Matching-Adjusted Indirect Comparison Implemented By A Resampling Method

    May 1, 2015, 00:00

  • Anticholinergic Medication use and risk of incident Fractures in the elderly with Depression

    May 1, 2015, 00:00

  • Economic burden of vaccine-preventable diseases among the elderly in Taiwan

    May 1, 2015, 00:00

  • Healthcare resource use among Patients with congestive Heart failure in a Large Health Organization

    May 1, 2015, 00:00

  • A Comparative Cost Utility Analysis For First Line Treatment Of Metastatic Non-Small Cell Lung Cancer (Nsclc) Patients With Egfr Exon 19 Deletions Or Exon 21 (L858r) Substitution Mutations

    May 1, 2015, 00:00

  • Increasing prevalence of ctx-m, tem and shv beta-lactamases in clinical pathogenic e. Coli causes significant health and economic losses- a perspective from pakistan

    May 1, 2015, 00:00

  • Study On The Inpatient Hospital Costs Of Hemorrhagic Stroke Inpatients In China

    May 1, 2015, 00:00

  • Interventions For Ultra-Rare Disorders (Urds) And The Logic Of Cost Effectiveness

    May 1, 2015, 00:00

  • Development and validation of a u.s. Administrative claims-based algorithm to classify patients with type 2 diabetes mellitus into renal impairment stages

    May 1, 2015, 00:00

  • Availability and affordability of Antiglaucoma Drugs in Benin City, Nigeria

    May 1, 2015, 00:00

  • OUTCOMES AND HEALTH RESOURCE UTILIZATION AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) AT AN ACADEMIC MEDICAL CENTER (AMC) IN THE UNITED STATES

    May 1, 2015, 00:00

  • Resource Utilization and costs associated with off-label use of atypical Antipsychotics in a Community-Dwelling Adult Population- findings from the Medical Expenditure Survey

    May 1, 2015, 00:00

  • Dosing pattern analysis for Biologics in the treatment of Psoriasis in Canada- indication-specific information retrieved from Administrative Claims Database

    May 1, 2015, 00:00

  • Sample Structure In A Prospective Study Of 22,000 Women Using Hormone Replacement Therapy (Hrt) Retained Unbiased After A Five-Year Follow-Up

    May 1, 2015, 00:00

  • Economic Impact Of Changes In Nicu Ventilation Strategies With The Advent Of New Noninvasive Ventilation Techniques- A Review And Proposed Assessment Framework For High Flow Therapy (Hft) As A Routine Respiratory Support Paradigm

    May 1, 2015, 00:00

  • A Descriptive Analysis of Patient Characteristics, Bleeding And Recurrence Risk Among U.S Veteran Patients Diagnosed With Venous Thromboembolism

    May 1, 2015, 00:00

  • Colorectal Cancer (CRC) costs in the us- findings from the Medical Expenditure Panel Survey 2008-2012

    May 1, 2015, 00:00

  • Combining Mcda With Advanced Statistics To Tackle Challenges Of Data And Judgment Uncertainty- Case Study Of Safety Assessments

    May 1, 2015, 00:00

  • Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research—Part 2- Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force

    Mar 1, 2015, 00:00

  • Strengthening Tuberculosis Control Overseas- Who Benefits?

    Mar 1, 2015, 00:00

  • Editorial Board

    Mar 1, 2015, 00:00

  • Cost-Utility Analyses in Diabetes- A Systematic Review and Implications from Real-World Evidence

    Mar 1, 2015, 00:00

  • Potential Application of Machine Learning in Health Outcomes Research and Some Statistical Cautions

    Mar 1, 2015, 00:00

  • The Changing Face of the Cost-Utility Literature, 1990–2012

    Mar 1, 2015, 00:00

  • Instructions for Authors

    Mar 1, 2015, 00:00

  • Copyright/Subscription

    Mar 1, 2015, 00:00

  • Economic Evaluation of Tocilizumab Monotherapy Compared to Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis

    Mar 1, 2015, 00:00

  • Clinical Trials Provide Essential Evidence, but Rarely Offer a Vehicle for Cost-Effectiveness Analysis

    Mar 1, 2015, 00:00

  • A Unified Framework for Classification of Methods for Benefit-Risk Assessment

    Mar 1, 2015, 00:00

  • Effect of Adherence and Insulin Delivery System on Clinical and Economic Outcomes among Patients with Type 2 Diabetes Initiating Insulin Treatment

    Mar 1, 2015, 00:00

  • Comparing the Cost-Effectiveness of Rituximab Maintenance and Radioimmunotherapy Consolidation versus Observation Following First-Line Therapy in Patients with Follicular Lymphoma

    Mar 1, 2015, 00:00

  • Public Preferences for Prioritizing Preventive and Curative Health Care Interventions- A Discrete Choice Experiment

    Mar 1, 2015, 00:00

  • Fairness versus Efficiency of Vaccine Allocation Strategies

    Mar 1, 2015, 00:00

  • Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

    Mar 1, 2015, 00:00

  • Erratum

    Mar 1, 2015, 00:00

  • Merging Regulatory and Reimbursement Needs in Clinical Trials

    Mar 1, 2015, 00:00

  • Application of Multicategory Exposure Marginal Structural Models to Investigate the Association between Long-Acting Beta-Agonists and Prescribing of Oral Corticosteroids for Asthma Exacerbations in the Clinical Practice Research Datalink

    Mar 1, 2015, 00:00

  • Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland? A Retrospective Analysis 2006–2013

    Mar 1, 2015, 00:00

  • Predictors of Self-Reported Adherence to Antihypertensive Medicines- A Multinational, Cross-Sectional Survey

    Mar 1, 2015, 00:00

  • Table of Contents

    Mar 1, 2015, 00:00

  • Dynamic Simulation in Health Care Comes of Age

    Mar 1, 2015, 00:00

  • A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part I- Descriptive Characteristics

    Mar 1, 2015, 00:00

  • Need for Multicriteria Evaluation of Generic Drug Policies

    Mar 1, 2015, 00:00

  • Mapping the Clinical Chronic Obstructive Pulmonary Disease Questionnaire onto Generic Preference-Based EQ-5D Values

    Mar 1, 2015, 00:00

  • Learning and Satisficing- An Analysis of Sequence Effects in Health Valuation

    Mar 1, 2015, 00:00

  • A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part II- Evaluation of Psychometric Performance of English-Language Versions in a General Population

    Mar 1, 2015, 00:00

  • Do the Current Performance-Based Schemes in Italy Really Work? “Success Fee”- A Novel Measure for Cost-Containment of Drug Expenditure

    Mar 1, 2015, 00:00

  • Implications of the Minimal Clinically Important Difference for Health-Related Quality-of-Life Outcomes- A Comparison of Sample Size Requirements for an Incontinence Treatment Trial

    Mar 1, 2015, 00:00

  • Critical Appraisal of Network Meta-Analyses Evaluating the Efficacy and Safety of New Oral Anticoagulants in Atrial Fibrillation Stroke Prevention Trials

    Mar 1, 2015, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96 (current)
  • 97
  • 98
  • 99
  • 100
  • »